Vioxx Trial – Round 1 – A Review

Here is an interesting article about the first Vioxx case that has made it to trial.

Look at the article’s description of the defense team:

“Judging from its lawyers involved in Ernst, Merck should have its own gallery of litigation support. Leading the case as co-chairs are Fulbright & Jaworski partner Gerry Lowry of Houston and partner David Kiernan of Washington, D.C.’s Williams & Connolly. They will be receiving assists from lawyers in Fulbright’s Houston and Dallas offices. Josephson and two other Baker Botts attorneys are also listed as counsel for Merck on court documents. And overseeing all Vioxx litigation on a national level is New York-based Hughes Hubbard & Reed.”

Here is an even more interesting article, this one from Fortune magazine.

Contact Information